Pfizer Inc. (PFE)
Pfizer is Locking in New Growth Through a New Acquisition
In the United States' healthcare sector, a new growth theme is emerging that nearly all companies want to capitalize on. Like artificial intelligence for technology stocks, weight loss drug manufacturing and distribution businesses are all the hype for this new growth wave taking over the industry.
Time to Buy Pfizer (PFE) or Metsera (MTSR) Stock?
Making a major move in the obesity drug market, Pfizer (PFE) announced on Monday that it plans to acquire biotechnology firm Metsera (MTSR).
Pfizer acquires Metsera in $7.3B deal to boost obesity drug pipeline
Pfizer Inc (NYSE:PFE, ETR:PFE) on Monday announced that it will acquire Metsera, Inc (NASDAQ: MTSR), a weight-loss drug developer, in a deal valued at up to $7.3 billion, or $47.50 per share in cash. Metsera is also eligible to receive an additional $22.50 per share contingent on the achievement of certain performance milestones.
Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal
Metsera's shareholders could see significant bonuses if certain milestones are reached.
Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports
Pfizer is closing in on a potential $7.3 billion takeover of anti-obesity drug developer Metsera , the Financial Times reported on Sunday, citing unidentified sources.
PFE vs. AZN: Which Cancer-Focused Drug Giant Is the Better Pick?
AstraZeneca and Pfizer both boast strong oncology pipelines, but growth paths, dividends and challenges set them apart for investors.
Pfizer: Dividend Cushion Ratio Brings Yield Sustainability Into Question
Pfizer Inc. faces significant uncertainty due to declining COVID-19 sales and potential policy changes. The uncertainties are further compounded by tariff risks and drug pricing policies under the MFN (most favorable nation) framework. A forward dividend yield of 7%+ can help put in a floor for the stock price amid these uncertainties.
Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively.
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
Shares of Pfizer and Moderna fell on Friday after a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children. The report comes as Health and Human Services Secretary Robert F.
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (September 2025)
Shares of Pfizer ( NYSE: PFE ) gained 4.50% over the past month after losing 6.50% the month prior.
Pfizer's Golden Cross Signals Strength: How to Play the Stock
Pfizer trades above key SMAs with a golden cross, while new drugs and cost cuts drive growth despite looming headwinds.
Pfizer lays off 100 employees in Seattle area
Pfizer laid off 100 employees in Bothell, Wash.
